TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01099917

Adverse event: Abdominal pain
Serious: yes
Organ System: Gastrointestinal disorders
Frequency: 1 affected / 21 at risk

Adverse event: Aphonia
Serious: yes
Organ System: General disorders
Frequency: 1 affected / 21 at risk

Adverse event: Confusional state
Serious: yes
Organ System: Nervous system disorders
Frequency: 1 affected / 21 at risk

Adverse event: Dyspnoea
Serious: yes
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 1 affected / 21 at risk

Adverse event: Brain oedema
Serious: yes
Organ System: Nervous system disorders
Frequency: 1 affected / 21 at risk

Adverse event: Eye disorders - Other
Serious: yes
Organ System: Eye disorders
Frequency: 1 affected / 21 at risk

Adverse event: Gastrointestinal disorders - Other
Serious: yes
Organ System: Gastrointestinal disorders
Frequency: 1 affected / 21 at risk

Adverse event: Leukocytosis
Serious: yes
Organ System: Blood and lymphatic system disorders
Frequency: 1 affected / 21 at risk

Adverse event: Pneumonia
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 21 at risk

Adverse event: Hemiparesis
Serious: yes
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 1 affected / 21 at risk

Adverse event: Platelet count decreased
Serious: yes
Organ System: Blood and lymphatic system disorders
Frequency: 1 affected / 21 at risk

Adverse event: Pruritus
Serious: yes
Organ System: Skin and subcutaneous tissue disorders
Frequency: 1 affected / 21 at risk

Adverse event: Cerebrovascular accident
Serious: yes
Organ System: Nervous system disorders
Frequency: 1 affected / 21 at risk

Adverse event: Wheezing
Serious: yes
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 1 affected / 21 at risk

Adverse event: Blood bilirubin increased
Serious: no
Organ System: Blood and lymphatic system disorders
Frequency: 2 affected / 21 at risk

Adverse event: Headache
Serious: no
Organ System: General disorders
Frequency: 4 affected / 21 at risk

Adverse event: Hyperglycaemia
Serious: no
Organ System: Metabolism and nutrition disorders
Frequency: 4 affected / 21 at risk

Adverse event: Lymphocyte count decreased
Serious: no
Organ System: Blood and lymphatic system disorders
Frequency: 2 affected / 21 at risk

Adverse event: Neutrophil count decreased
Serious: no
Organ System: Blood and lymphatic system disorders
Frequency: 10 affected / 21 at risk

Adverse event: Pain in extremity
Serious: no
Organ System: General disorders
Frequency: 2 affected / 21 at risk

Adverse event: Platelet count decreased
Serious: no
Organ System: Blood and lymphatic system disorders
Frequency: 9 affected / 21 at risk

Adverse event: White blood cell count decreased
Serious: no
Organ System: Blood and lymphatic system disorders
Frequency: 11 affected / 21 at risk
Study: NCT01100073

Adverse event: Spinal fracture
Serious: yes
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 1 affected / 1699 at risk

Adverse event: Acute Stroke
Serious: yes
Organ System: Nervous system disorders
Frequency: 1 affected / 1699 at risk

Adverse event: Myocardial infarction
Serious: yes
Organ System: Cardiac disorders
Frequency: 1 affected / 1699 at risk
Study: NCT01100086

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 11 affected / 84 at risk

Adverse event: Dizziness
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 6 affected / 84 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 6 affected / 84 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 10 affected / 83 at risk

Adverse event: Dizziness
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 1 affected / 83 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 3 affected / 83 at risk
Study: NCT01100112

Adverse event: Colitis ulcerative
Serious: yes
Organ System: Gastrointestinal disorders
Frequency: 1 affected / 60 at risk

Adverse event: Endometrial hyperplasia
Serious: yes
Organ System: Reproductive system and breast disorders
Frequency: 1 affected / 60 at risk

Adverse event: Cushingoid
Serious: no
Organ System: Endocrine disorders
Frequency: 3 affected / 60 at risk

Adverse event: Diarrhoea
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 2 affected / 60 at risk

Adverse event: Asthenia
Serious: no
Organ System: General disorders
Frequency: 2 affected / 60 at risk

Adverse event: Pyrexia
Serious: no
Organ System: General disorders
Frequency: 2 affected / 60 at risk

Adverse event: Urinary tract infection
Serious: no
Organ System: Infections and infestations
Frequency: 7 affected / 60 at risk

Adverse event: Cortisol decreased
Serious: no
Organ System: Investigations
Frequency: 9 affected / 60 at risk

Adverse event: Blood glucose decreased
Serious: no
Organ System: Investigations
Frequency: 2 affected / 60 at risk

Adverse event: Blood potassium increased
Serious: no
Organ System: Investigations
Frequency: 2 affected / 60 at risk
Study: NCT01100255

Adverse event: Dizziness
Serious: no
Organ System: Nervous system disorders
Notes: Dizziness resolved within 110min of the start of the infusion.
Frequency: 3 affected / 15 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Notes: Nausea resolved within 110min of the start of the infusion.
Frequency: 2 affected / 15 at risk

Adverse event: Vomiting
Serious: no
Organ System: Gastrointestinal disorders
Notes: Vomiting resolved within 110min of the start of the infusion.
Frequency: 1 affected / 15 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Notes: Headache resolved within 110min of the start of the infusion.
Frequency: 2 affected / 15 at risk
Study: NCT01100320

Adverse event: Substance Abuse (positive for cocaine, amphetamine, and MDMA)
Serious: yes
Organ System: Social circumstances
Frequency: 1 affected / 81 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 15 affected / 81 at risk

Adverse event: Vomiting
Serious: no
Organ System: Gastrointestinal disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 7 affected / 81 at risk

Adverse event: Dizziness
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 5 affected / 81 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 8 affected / 81 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 12 affected / 83 at risk

Adverse event: Vomiting
Serious: no
Organ System: Gastrointestinal disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 4 affected / 83 at risk

Adverse event: Dizziness
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 3 affected / 83 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 3 affected / 83 at risk
Study: NCT01100775

Adverse event: Dizziness
Serious: no
Organ System: General disorders
Notes: Participant reported felling dizzy after taking study medication or placebo
Frequency: 2 affected / 12 at risk

Adverse event: Euphoric mood
Serious: no
Organ System: General disorders
Notes: Participant reported felling euphoric during testing
Frequency: 1 affected / 12 at risk

Adverse event: Somnolence
Serious: no
Organ System: General disorders
Notes: Participant reported feeling drowsy during testing
Frequency: 1 affected / 12 at risk

Adverse event: Vision blurred
Serious: no
Organ System: General disorders
Notes: Participant reported blurry vision during testing
Frequency: 1 affected / 12 at risk

Adverse event: Tearing of Eyes
Serious: no
Organ System: General disorders
Notes: Participant reported tearing in their eyes during testing
Frequency: 1 affected / 12 at risk

Adverse event: Insomnia
Serious: no
Organ System: General disorders
Notes: Participant reported difficulty sleeping after starting study medication or placebo
Frequency: 2 affected / 12 at risk

Adverse event: Nausea
Serious: no
Organ System: General disorders
Notes: Participant reported felling nauseous after starting study medication or placebo
Frequency: 2 affected / 12 at risk

Adverse event: Headache
Serious: no
Organ System: General disorders
Notes: Participant reported headache after starting study medication or placebo
Frequency: 1 affected / 12 at risk

Adverse event: Malaise
Serious: no
Organ System: General disorders
Notes: Participant reported malaise/physical fatigue after starting study medication or placebo
Frequency: 1 affected / 12 at risk

Adverse event: Sedation
Serious: no
Organ System: General disorders
Notes: Participant reported sedation after starting study medication or placebo
Frequency: 1 affected / 12 at risk

Adverse event: Dry mouth
Serious: no
Organ System: General disorders
Notes: Participant reported dry mouth after starting study medication or placebo
Frequency: 1 affected / 12 at risk

Adverse event: Abdominal pain
Serious: no
Organ System: General disorders
Notes: Participant reported abdominal pain after starting study medication or placebo
Frequency: 1 affected / 12 at risk

Adverse event: Headache
Serious: no
Organ System: General disorders
Notes: Participant reported headache after starting study medication or placebo
Frequency: 1 affected / 12 at risk
Study: NCT01100853

Adverse event: Hospitilization due to relapse to substance disorder
Serious: yes
Organ System: Psychiatric disorders
Frequency: 7 affected / 51 at risk

Adverse event: Abdominal pain, elevated liver enzymes
Serious: yes
Organ System: Hepatobiliary disorders
Frequency: 1 affected / 51 at risk

Adverse event: Potential suicide attempt
Serious: yes
Organ System: Psychiatric disorders
Frequency: 1 affected / 51 at risk

Adverse event: Nausea, diarrhea, discomfort/pain from stomach, heartburn
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 8 affected / 51 at risk

Adverse event: Symptoms of depression and/or anxiety
Serious: no
Organ System: Psychiatric disorders
Frequency: 5 affected / 51 at risk

Adverse event: Dizziness, fatigue, fainting sensation
Serious: no
Organ System: Nervous system disorders
Frequency: 6 affected / 51 at risk

Adverse event: Elevated ALT level >5 times normal range
Serious: no
Organ System: Hepatobiliary disorders
Frequency: 1 affected / 51 at risk

Adverse event: Headache
Serious: no
Organ System: General disorders
Frequency: 4 affected / 51 at risk

Adverse event: Other, feeling unwell, fever, loss of appetite, joint pain, pruritus, sore throat, etc.
Serious: no
Organ System: General disorders
Frequency: 4 affected / 51 at risk

Adverse event: Hospitilization due to relapse to substance disorder
Serious: yes
Organ System: Psychiatric disorders
Frequency: 6 affected / 49 at risk

Adverse event: Pneumothorax
Serious: yes
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 1 affected / 49 at risk

Adverse event: Nausea, diarrhea, discomfort/pain from stomach, heartburn
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 7 affected / 49 at risk

Adverse event: Skin and subcutaneous tissue disorders
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 5 affected / 49 at risk

Adverse event: Symptoms of depression and/or anxiety
Serious: no
Organ System: Psychiatric disorders
Frequency: 2 affected / 49 at risk

Adverse event: Dizziness, fatigue, fainting sensation
Serious: no
Organ System: Nervous system disorders
Frequency: 3 affected / 49 at risk

Adverse event: Elevated ALT level >5 times normal range
Serious: no
Organ System: Hepatobiliary disorders
Frequency: 2 affected / 49 at risk

Adverse event: Headache
Serious: no
Organ System: General disorders
Frequency: 5 affected / 49 at risk

Adverse event: Other, feeling unwell, fever, loss of appetite, joint pain, pruritus, sore throat, etc.
Serious: no
Organ System: General disorders
Frequency: 3 affected / 49 at risk
Study: NCT01101165

Adverse event: Substance abuse (positive for cotinine and amphetamines)
Serious: yes
Organ System: Social circumstances
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 1 affected / 87 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 8 affected / 87 at risk

Adverse event: Vomiting
Serious: no
Organ System: Gastrointestinal disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 3 affected / 87 at risk

Adverse event: Fatigue
Serious: no
Organ System: General disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 11 affected / 87 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 8 affected / 87 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 7 affected / 90 at risk

Adverse event: Vomiting
Serious: no
Organ System: Gastrointestinal disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 7 affected / 90 at risk

Adverse event: Fatigue
Serious: no
Organ System: General disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 7 affected / 90 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 11 affected / 90 at risk
Study: NCT01101178

Adverse event: Positive drug screen (Cocaine)
Serious: yes
Organ System: Social circumstances
Frequency: 1 affected / 75 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Notes: systematic and nonsystematic assessments were used for reporting AEs
Frequency: 13 affected / 75 at risk

Adverse event: Vomiting
Serious: no
Organ System: Gastrointestinal disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 3 affected / 75 at risk

Adverse event: Fatigue
Serious: no
Organ System: General disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 4 affected / 75 at risk

Adverse event: Dizziness
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 9 affected / 75 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 16 affected / 75 at risk

Adverse event: Somnolence
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 8 affected / 75 at risk

Adverse event: Positive drug screen (Cannabinoids)
Serious: yes
Organ System: Social circumstances
Frequency: 1 affected / 75 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Notes: systematic and nonsystematic assessments were used for reporting AEs
Frequency: 8 affected / 75 at risk

Adverse event: Vomiting
Serious: no
Organ System: Gastrointestinal disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 5 affected / 75 at risk

Adverse event: Fatigue
Serious: no
Organ System: General disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 3 affected / 75 at risk

Adverse event: Dizziness
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 5 affected / 75 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 14 affected / 75 at risk

Adverse event: Somnolence
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 8 affected / 75 at risk

Adverse event: Positive drug screen (Cannabinoids)
Serious: yes
Organ System: Social circumstances
Frequency: 2 affected / 169 at risk
Study: NCT01101191

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 10 affected / 82 at risk

Adverse event: Vomiting
Serious: no
Organ System: Gastrointestinal disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 8 affected / 82 at risk

Adverse event: Fatigue
Serious: no
Organ System: General disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 6 affected / 82 at risk

Adverse event: Dizziness
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 9 affected / 82 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 12 affected / 82 at risk

Adverse event: Somnolence
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 2 affected / 82 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 15 affected / 82 at risk

Adverse event: Vomiting
Serious: no
Organ System: Gastrointestinal disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 11 affected / 82 at risk

Adverse event: Fatigue
Serious: no
Organ System: General disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 7 affected / 82 at risk

Adverse event: Dizziness
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 11 affected / 82 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 19 affected / 82 at risk

Adverse event: Somnolence
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 6 affected / 82 at risk

Adverse event: Positive drug test
Serious: yes
Organ System: Social circumstances
Frequency: 1 affected / 136 at risk
Study: NCT01101308

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 6 affected / 52 at risk

Adverse event: Puncture site pain
Serious: no
Organ System: General disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 4 affected / 52 at risk

Adverse event: Dizziness
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 5 affected / 52 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 6 affected / 52 at risk

Adverse event: Ecchymosis
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 4 affected / 52 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 7 affected / 54 at risk

Adverse event: Puncture site pain
Serious: no
Organ System: General disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 2 affected / 54 at risk

Adverse event: Dizziness
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 3 affected / 54 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 4 affected / 54 at risk

Adverse event: Ecchymosis
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Systematic and nonsystematic assessments were used for reporting AEs.
Frequency: 1 affected / 54 at risk

Adverse event: Positive drug screen (cannabanoids)
Serious: yes
Organ System: Social circumstances
Frequency: 1 affected / 124 at risk